Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 76 from CROI 2019
THURSDAY PLENARY SESSION
THE CHALLENGES OF HIV TREATMENT IN AN ERA OF POLYPHARMACY   (ABSTRACT 120)
David Back
University of Liverpool, Liverpool, United Kingdom
from CROI 2019 on March 7, 2019 8:30 AM-9:30 AM
THURSDAY PLENARY SESSION
NEUROHIV: WHAT THE VIRUS TELLS US   (ABSTRACT 121)
Ronald Swanstrom
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2019 on March 7, 2019 8:30 AM-9:30 AM
ORAL ABSTRACT: ANTIRETROVIRAL CLINICAL TRIALS AND RESISTANCE
SEARCH INTERVENTION REDUCES MORTALITY AT A POPULATION LEVEL IN MEN WITH LOW CD4 COUNT   (ABSTRACT 138)
Moses R. Kamya
Makerere University College of Health Sciences, Kampala, Uganda
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: ANTIRETROVIRAL CLINICAL TRIALS AND RESISTANCE
LONG-ACTING CABOTEGRAVIR + RILPIVIRINE AS MAINTENANCE THERAPY: ATLAS WEEK 48 RESULTS   (ABSTRACT 139)
Susan Swindells
University of Nebraska Medical Center, Omaha, NE, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: ANTIRETROVIRAL CLINICAL TRIALS AND RESISTANCE
LONG-ACTING CABOTEGRAVIR + RILPIVIRINE FOR HIV MAINTENANCE: FLAIR WEEK 48 RESULTS   (ABSTRACT 140)
Chloe Orkin
Barts Health NHS Trust, London, United Kingdom
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: ANTIRETROVIRAL CLINICAL TRIALS AND RESISTANCE
SAFETY AND PK OF SUBCUTANEOUS GS-6207, A NOVEL HIV-1 CAPSID INHIBITOR   (ABSTRACT 141)
Jennifer E Sager
Gilead Sciences, Foster City, CA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: ANTIRETROVIRAL CLINICAL TRIALS AND RESISTANCE
A PHASE IIA STUDY OF NOVEL MATURATION INHIBITOR GSK2838232 IN HIV PATIENTS   (ABSTRACT 142)
Edwin DeJesus
Orlando Immunology Center, Orlando, FL, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: ANTIRETROVIRAL CLINICAL TRIALS AND RESISTANCE
SYSTEMATIC DETERMINATION OF IN VITRO HIV-1 INTEGRASE RESISTANCE FROM CLINICAL SAMPLES   (ABSTRACT 143)
Aniqa Shahid
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: ANTIRETROVIRAL CLINICAL TRIALS AND RESISTANCE
DTG VS LPV/R (DAWNING): EFFICACY BY BASELINE NRTI RESISTANCE AND SECOND-LINE NRTI USE   (ABSTRACT 144)
Dannae Brown
ViiV Healthcare, Surry Hills, NSW, Australia
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: ANTIRETROVIRAL CLINICAL TRIALS AND RESISTANCE
THERAPEUTIC ACTIVITY OF PGT121 MONOCLONAL ANTIBODY IN HIV-INFECTED ADULTS   (ABSTRACT 145)
Kathryn E. Stephenson
Beth Israel Deaconess Medical Center, Boston, MA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV/SIV AND THE IMMUNE SYSTEM: AN INTIMATE DANCE
HIGH HIV VIRAL BURDEN PERSISTS IN CXCR3+ GCTFH DESPITE VERY EARLY ART INITIATION   (ABSTRACT 130)
Zaza Ndhlovu
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV/SIV AND THE IMMUNE SYSTEM: AN INTIMATE DANCE
SIROLIMUS REDUCES T-CELL CYCLING AND IMMUNE CHECKPOINT MARKER EXPRESSION, ACTG A5337   (ABSTRACT 131)
Timothy J Henrich
UCSF, San Francisco, CA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV/SIV AND THE IMMUNE SYSTEM: AN INTIMATE DANCE
PD-1 AND CTLA-4 BLOCKADE IN MACAQUES INDUCES T-CELL EXPANSION AND SIV REACTIVATION   (ABSTRACT 132)
Mirko Paiardini
Emory University School of Medicine, Atlanta, GA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV/SIV AND THE IMMUNE SYSTEM: AN INTIMATE DANCE
FTY720 LIMITS T FOLLICULAR HELPER CELL INFECTION IN LYMPHOID SITES OF SIV PERSISTENCE   (ABSTRACT 133)
Maria Pino
Yerkes National Primate Research Center, Atlanta, GA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV/SIV AND THE IMMUNE SYSTEM: AN INTIMATE DANCE
TRANSCRIPTIONAL SIGNATURE OF LYMPH NODE CD8+ T CELLS IN HIV ELITE CONTROLLERS   (ABSTRACT 134)
Son Nguyen
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV/SIV AND THE IMMUNE SYSTEM: AN INTIMATE DANCE
CHARACTERIZING THE PROVIRAL LANDSCAPE IN HIV-1 ELITE CONTROLLERS   (ABSTRACT 135)
Chenyang Jiang
Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV/SIV AND THE IMMUNE SYSTEM: AN INTIMATE DANCE
INTERFERON Α2B REDUCES INDUCIBLE CD4-ASSOCIATED HIV IN ART-SUPPRESSED INDIVIDUALS   (ABSTRACT 136)
Livio Azzoni
The Wistar Institute, Philadelphia, PA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV/SIV AND THE IMMUNE SYSTEM: AN INTIMATE DANCE
NEF-STOP REPAIR DYNAMICS, BUT NOT ANTI-Α4Β7, INFLUENCE POSTTREATMENT VIRAL CONTROL   (ABSTRACT 137)
Michele Di Mascio
NIAID, Rockville, MD, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: PROGRAMMATIC AND SCIENTIFIC ISSUES IN IMPLEMENTING HIV TREATMENT AND MONITORING
MORTALITY REDUCTION IN WESTERN KENYA DURING SCALE-UP OF HIV TREATMENT, 2011-2016   (ABSTRACT 146)
Emily C. Zielinski-Gutierrez
US Centers for Disease Control and Prevention, Nairobi, Kenya
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: PROGRAMMATIC AND SCIENTIFIC ISSUES IN IMPLEMENTING HIV TREATMENT AND MONITORING
OPIOID OVERDOSE DEATHS AMONG PERSONS WITH HIV INFECTION, UNITED STATES, 2011-2015   (ABSTRACT 147)
Karin A. Bosh
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: PROGRAMMATIC AND SCIENTIFIC ISSUES IN IMPLEMENTING HIV TREATMENT AND MONITORING
EARLY MORTALITY IN HIV-INFECTED PATIENTS INITIATING ART WITHOUT A PRETHERAPY CD4   (ABSTRACT 148)
Kombatende Sikombe
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: PROGRAMMATIC AND SCIENTIFIC ISSUES IN IMPLEMENTING HIV TREATMENT AND MONITORING
UTILITY OF CD4 CELL COUNT MONITORING IN BOTSWANA: ANALYSIS OF ROUTINE LABORATORY DATA   (ABSTRACT 149)
Tshepo Botho Leeme
Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: PROGRAMMATIC AND SCIENTIFIC ISSUES IN IMPLEMENTING HIV TREATMENT AND MONITORING
TRENDS IN CD4 AND VIRAL LOAD TESTING IN SOUTHERN AFRICA: ANALYSIS OF 6 COUNTRIES   (ABSTRACT 150)
Matthias Egger
University of Bern / Switzerland, Bern, Switzerland
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: PROGRAMMATIC AND SCIENTIFIC ISSUES IN IMPLEMENTING HIV TREATMENT AND MONITORING
HIGH LEVELS OF DRUG RESISTANCE AMONG ART-EXPERIENCED HOSPITALIZED PATIENTS   (ABSTRACT 151)
Claire Bossard
Médecins Sans Frontières, Cape Town, South Africa
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: PROGRAMMATIC AND SCIENTIFIC ISSUES IN IMPLEMENTING HIV TREATMENT AND MONITORING
HIV DRUG RESISTANCE IN SOUTH AFRICA: RESULTS FROM A POPULATION-BASED HOUSEHOLD SURVEY   (ABSTRACT 152)
Sizulu Moyo
Human Sciences Research Council, Cape Town, South Africa
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: PROGRAMMATIC AND SCIENTIFIC ISSUES IN IMPLEMENTING HIV TREATMENT AND MONITORING
DURATION OF INFECTIOUSNESS AMONG PERSONS WITH HIV DIAGNOSED DURING 2012-2016   (ABSTRACT 153)
Nicole Crepaz
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: SUPPRESSIVE ART AND THE CNS: SWITCHES, OUTCOMES, AND BIOMARKERS
BRAIN CONNECTIVITY IN NEUROLOGICALLY ASYMPTOMATIC PEOPLE WITH HIV SWITCHING ART   (ABSTRACT 122)
Jaime H Vera
Brighton and Sussex Medical School, University of Sussex, Brighton, East Sussex, United Kingdom
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: SUPPRESSIVE ART AND THE CNS: SWITCHES, OUTCOMES, AND BIOMARKERS
DEEP-LEARNING CEREBRAL BLOOD FLOW FOR COGNITIVE-IMPAIRMENT CLASSIFICATION IN HIV   (ABSTRACT 123)
Patrick Luckett
Washington University in St Louis, St Louis, MO, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: SUPPRESSIVE ART AND THE CNS: SWITCHES, OUTCOMES, AND BIOMARKERS
HOST GLYCOMIC DETERMINANTS OF HIV-ASSOCIATED NEUROCOGNITIVE IMPAIRMENT DURING THERAPY   (ABSTRACT 124)
Leila Bertoni Giron
The Wistar Institute, Philadelphia, PA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: SUPPRESSIVE ART AND THE CNS: SWITCHES, OUTCOMES, AND BIOMARKERS
CSF SCD30 ELEVATION DESPITE SUPPRESSIVE ART SUGGESTS CNS HIV PERSISTENCE   (ABSTRACT 125)
Michael Peluso
University of California - San Francisco, San Francisco, CA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: SUPPRESSIVE ART AND THE CNS: SWITCHES, OUTCOMES, AND BIOMARKERS
CSF HIV RNA DETECTED AT <20 COPIES/ML ASSOCIATES WITH BLOOD-BRAIN BARRIER MEASURES   (ABSTRACT 126)
Shelli Farhadian
Yale School of Medicine, New Haven, CT, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: SUPPRESSIVE ART AND THE CNS: SWITCHES, OUTCOMES, AND BIOMARKERS
EFFECT ON PLASMA NFL, A MARKER OF NEURONAL INJURY, AFTER SWITCHING FROM TDF TO TAF   (ABSTRACT 127)
Linn Hermansson
Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: SUPPRESSIVE ART AND THE CNS: SWITCHES, OUTCOMES, AND BIOMARKERS
CARDIOVASCULAR RISK SCORES PREDICT LONGITUDINAL COGNITIVE FUNCTION IN OLDER PLHIV   (ABSTRACT 128)
Felicia C Chow
UCSF, San Francisco, CA, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: SUPPRESSIVE ART AND THE CNS: SWITCHES, OUTCOMES, AND BIOMARKERS
OBESITY IS INDEPENDENTLY ASSOCIATED WITH NEUROCOGNITIVE DECLINE IN HIV   (ABSTRACT 129)
Kristine M Erlandson
University of Colorado, Aurora, CO, USA
from CROI 2019 on March 7, 2019 10:00 AM-12:00 PM
THEMED DISCUSSION: ART: InSTIs AND TOXICITY
THEMED DISCUSSION LEADER
Alan Winston
Imperial College London, London, United Kingdom
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: ART: InSTIs AND TOXICITY
NEUROPSYCHIATRIC OUTCOMES BEFORE AND AFTER SWITCHING TO DOLUTEGRAVIR-BASED THERAPY   (ABSTRACT 440)
Phillip Chan
SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: ART: InSTIs AND TOXICITY
NEUROPSYCHOLOGICAL CHANGES IN EFAVIRENZ SWITCH REGIMENS IN MACS   (ABSTRACT 441)
Yijia Li
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: ART: InSTIs AND TOXICITY
MEMORY AND LEARNING DYSFUNCTION WITH INTEGRASE STRAND TRANSFER INHIBITORS USE   (ABSTRACT 442)
Jane A O'Halloran
Washington University in St Louis, St Louis, MO, USA
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: ART: InSTIs AND TOXICITY
CEREBRAL FUNCTION PARAMETERS IN PEOPLE LIVING WITH HIV SWITCHING INTEGRASE INHIBITOR   (ABSTRACT 443)
Borja Mora-Peris
Imperial College London, London, United Kingdom
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: ART: InSTIs AND TOXICITY
CENTRAL NERVOUS SYSTEM EFFECTS OF THERAPY INITIATION WITH INTEGRASE INHIBITORS   (ABSTRACT 439)
Jose A. Muñoz-Moreno
Lluita contra la SIDA Foundation - Germans Trias i Pujol University Hospital, Badalona, Barcelona, Catalonia, Spain
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: ART: InSTIs AND TOXICITY
QUESTIONS AND ANSWERS
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: HBV: RACING HIV FOR THE CURE
THEMED DISCUSSION LEADER
Debika Bhattacharya
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: HBV: RACING HIV FOR THE CURE
HEPATITIS B CURE IN HIV PATIENTS IS MORE LIKELY IN HISPANICS AND THOSE WITH AIDS   (ABSTRACT 624)
Mamta K Jain
University of Texas Southwestern Medical Center, Dallas, TX, USA
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: HBV: RACING HIV FOR THE CURE
HIGH RATES OF HBV FUNCTIONAL CURE AMONG HIV/HBV-COINFECTED PATIENTS ON ART IN ZAMBIA   (ABSTRACT 625)
Belinda Varaidzo Chihota
Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: HBV: RACING HIV FOR THE CURE
HEPATITIS B VIROLOGIC FAILURE OF TENOFOVIR-BASED THERAPIES IN PATIENTS WITH HIV/HBV   (ABSTRACT 626)
Meredith Mock
Duke University, Durham, NC, USA
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: HBV: RACING HIV FOR THE CURE
HIV LATE PRESENTATION AND ITS IMPACT ON HBV SEROCONVERSION IN HBV/HIV   (ABSTRACT 627)
Christoph Boesecke
University Hospital Bonn, Bonn, Germany
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: HBV: RACING HIV FOR THE CURE
ABSENCE OF HBV REACTIVATION IN HIV/HCV/HBCAB COINFECTED PATIENTS TREATED WITH DAA   (ABSTRACT 628)
Maddalena Cerrone
Chelsea and Westminster Hospital NHS Trust, London, UK, London, United Kingdom
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: HBV: RACING HIV FOR THE CURE
QUESTIONS AND ANSWERS
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: PrEP IN FITS AND STARTS
THEMED DISCUSSION LEADER
James A. McIntyre
Anova Health Institute, Johannesburg, South Africa
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: PrEP IN FITS AND STARTS
CHANGES IN KIDNEY FUNCTION AMONG MSM INITIATING ON-DEMAND TDF/FTC FOR HIV PREP   (ABSTRACT 960)
Geoffroy Liegeon
AP-HP, Hopital Saint Louis, Paris, France
from CROI 2019 on March 7, 2019 1:30 PM-2:30 PM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 76 from CROI 2019